Annexon (ANNX) Earnings Date & Reports

A.I. Advisor

published Earnings

ANNX is expected to report earnings to rise 19.00% to -27 cents per share on November 18

Q3'24

Est.

$-0.27

Q2'24

Est.

$-0.23

Q1'24

Beat

by $0.13

Q4'23

Beat

by $0.09

Q3'23

Beat

by $0.07

The last earnings report on August 12 showed earnings per share of -23 cents, meeting the estimate of -23 cents. With 877.94K shares outstanding, the current market capitalization sits at 648.72M.

View a ticker or compare two or three

Compare

ANNX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ANNX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ANNX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1400 Sierra Point Parkway

Phone

+1 650 822-5500

Employees

Web

https://www.annexonbio.com